MECHANISMS OF ACQUIRED RESISTANCE TO CETUXIMAB: ROLE OF HER (ErbB) FAMILY MEMBERS

The epidermal growth factor receptor (EGFR) is a central regulator of proliferation and progression in human cancers. Five EGFR inhibitors, two monoclonal antibodies and three TKIs, have recently gained FDA approval in oncology (cetuximab, panitumumab, erlotinib, gefitinib and lapatinib). These stra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wheeler, Deric L., Huang, Shyhmin, Kruser, Tim J., Nechrebecki, Meghan M., Armstrong, Eric A., Benavente, Sergio, Gondi, Vinai, Hsu, Kun-Tai, Harari, Paul M.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903615/
https://ncbi.nlm.nih.gov/pubmed/18297114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2008.19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars